PROTACs: Targeting breakdown of specific proteins to treat diseases
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
clinical trials
Continue reading
Metformin: The age-old elixir of life?
Ayush Sinha examines metformin’s role in longevity and reports on the highly-anticipated TAME trial set to further investigate its potential.
The science of skinny: Ozempic reinforces the obsession with thinness
Isabelle Goodall-Summers explores the off-label use of Ozempic for weight loss, highlighting potential societal implications.
The legacy of a girl who inspired a “holy grail” cancer-killing pill
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Checkpoints: Progress in cancer immunotherapy
Cecilia Jay describes the challenges facing immunotherapy as cancer treatment, and its potential to revolutionise personalised medicine .
A Potential Breakthrough in HIV Vaccine Development
Andrew Griffiths reports on results from a small-scale clinical trial showing a potential breakthrough in HIV vaccine development.
Transfusion of lab-grown red blood cells in pioneering clinical trial could revolutionise treatment of rare blood disorders
Caius Gibeily reports on the promising results from a phase I trial which transfused lab-grown red blood cells into healthy patients.
Have we finally found an effective vaccine against malaria?
Andrew Griffiths reports on the recently published findings from a malaria vaccine trial—do we now have an effective vaccine against malaria?
Do antidepressants actually work?
Joshua Mitchell reviews the debate over the role of serotonin in depression, and the evidence on whether antidepressants do actually work.
Vaccine drink entering trials in Oxford
By Karen Heathcote We’ve seen and heard plenty about vaccines over the last couple of years, with news outlets all over the world proudly showing images of people receiving their COVID-19 vaccination jabs. However, a new vaccine that is about to enter its next phase of trials in Oxford won’t be administered as an injection…